Scientific paper - Original scientific paper
Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT
Journal of Hematology & Oncology, 12 (2019), 1; 108. https://doi.org/10.1186/s13045-019-0790-x

Pavlů, Jiří; Labopin, Myriam; Niittyvuopio, Riitta; Socié, Gerard; Yakoub-Agha, Ibrahim; Wu, Depei; Remenyi, Peter; Passweg, Jakob; Beelen, Dietrich W.; Aljurf, Mahmoud; Kröger, Nicolaus; Labussière-Wallet, Hélène; Perić, Zinaida; Giebel, Sebastian; Nagler, Arnon; Mohty, Mohamad More authors...

Cite this document

Pavlů, J., Labopin, M., Niittyvuopio, R., Socié, G., Yakoub Agha, I., Wu, D. ... Mohty, M. (2019). Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT. Journal of Hematology & Oncology, 12. (1). doi: 10.1186/s13045-019-0790-x

Pavlů, Jiří, et al. "Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT." Journal of Hematology & Oncology, vol. 12, no. 1, 2019. https://doi.org/10.1186/s13045-019-0790-x

Pavlů, Jiří, Myriam Labopin, Riitta Niittyvuopio, Gerard Socié, Ibrahim Yakoub Agha, Depei Wu, Peter Remenyi, et al. "Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT." Journal of Hematology & Oncology 12, no. 1 (2019). https://doi.org/10.1186/s13045-019-0790-x

Pavlů, J., et al. (2019) 'Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT', Journal of Hematology & Oncology, 12(1). doi: 10.1186/s13045-019-0790-x

Pavlů J, Labopin M, Niittyvuopio R, Socié G, Yakoub Agha I, Wu D, and sur.. Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT. Journal of Hematology & Oncology [Internet]. 2019 October 23 [cited 2024 October 05];12(1). doi: 10.1186/s13045-019-0790-x

J. Pavlů, et al., "Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT", Journal of Hematology & Oncology, vol. 12, no. 1, October 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:030394. [Accessed: 05 October 2024]

Please login to the repository to save this object to your list.